Biogate Precision Medicine Corp.

This is the first human study of an experimental cancer drug called BGM-2121. Researchers will test it in 35 adults with advanced solid tumors who have already tried standard treatments. The main goals are to find the safest dose and see how the body handles the drug, while also …